Cellular Immunology Proficiency Testing Program

Mourtzinos N, Puri PK, Wang G, Liu ML. CD4/CD8 double negative pagetoid reticulosis: a case report and literature review. J Cutan Pathol. 2009 Jul 10.

Magerus-Chatinet A, Stolzenberg MC, Loffredo MS, Neven B, Schaffner C, Ducrot N, Arkwright PD, Bader-Meunier B, Barbot J, Blanche S, Casanova JL, Debré M, Ferster A, Fieschi C, Florkin B, Galambrun C, Hermine O, Lambotte O, Solary E, Thomas C, Le Deist F, Picard C, Fischer A, Rieux-Laucat F. FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function. Blood 113:3027-3030,2009.

Feyler S, von Lilienfeld-Toal M, Jarmin S, Marles L, Rawstron A, Ashcroft AJ, Owen RG, Selby PJ, Cook G. CD4⁺CD25⁺FoxP3⁺ regulatory T cells are increased whilst CD3⁺CD4^-CD8^- alphabetaTCR⁺ Double Negative T cells are decreased in the peripheral blood of patients with multiple myeloma which correlates with disease burden. Br J Haematol. 144:686-695, 2009.

Crispín JC, Oukka M, Bayliss G, Cohen RA, Van Beek CA, Stillman IE, Kyttaris VC, Juang YT, Tsokos GC. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J Immunol. 181:8761-8766, 2008.

Bristeau-Leprince A, Mateo V, Lim A, Magerus-Chatinet A, Solary E, Fischer A, Rieux-Laucat F, Gougeon ML. Human TCR alpha/beta⁺ CD4^-CD8 ^- double-negative T cells in patients with autoimmune lymphoproliferative syndrome express restricted Vbeta TCR diversity and are clonally related to CD8⁺ T cells. J Immunol. 181:440-448, 2008.

McIver Z, Serio B, Dunbar A, O'Keefe CL, Powers J, Wlodarski M, Jin T, Sobecks R, Bolwell B, Maciejewski JP. Double-negative regulatory T cells induce allotolerance when expanded after allogeneic haematopoietic stem cell transplantation. Br J Haematol. 141:170-8, 2008.

Marlies A, Udo G, Juergen B, Bernd S, Herrmann M, Haas JP. The expanded double negative T cell populations of a patient with ALPS are not clonally related to CD4⁺ or to CD8⁺ T cells. Autoimmunity. 40:299-301, 2007.

Alavi S, Taghi Arzanian M, Chavoshzadeh Z, Esteghamati M. Autoimmune lymphoproliferative syndrome; a case report. Iran J Allergy Asthma Immunol. 4:149-152, 2005.

Cheney KM, Kumar R, Purins A, Mundy L, Ferguson W, Shaw D, Burrell CJ, Li P. HIV type 1 persistence in CD4- /CD8- double negative T cells from patients on antiretroviral therapy. AIDS Res Hum Retroviruses. 22:66-75, 2006.

Howe R, Dillon S, Rogers L, Palmer B, MaWhinney S, Blyveis N, Schlichtemeier R, D'Souza M, Ingoldby L, Harwood JE, Rietmeijer C, Ray G, Connick E, Wilson CC. Phenotypic and functional characterization of HIV-1-specific CD4⁺CD8⁺ double-positive T cells in early and chronic HIV-1 infection. J Acquir Immune Defic Syndr. 50:444-456, 2009.

Desfrançois J, Derré L, Corvaisier M, Le Mével B, Catros V, Jotereau F, Gervois N. Increased frequency of nonconventional double positive CD4CD8 alphabeta T cells in human breast pleural effusions. Int J Cancer. 125:374-380, 2009.

Rahemtullah A, Harris NL, Dorn ME, Preffer FI, Hasserjian RP. Beyond the lymphocyte predominant cell: CD4⁺CD8⁺ T-cells in nodular lymphocyte predominant Hodgkin lymphoma. Leuk Lymphoma. 49:1870-1878, 2008.

Martinez-Gallo M, Puy C, Ruiz-Hernandez R, Rodriguez-Arias JM, Bofill M, Nomdedeu JF, Cigudosa JC, Rodriguez-Sanchez JL, de la Calle-Martin O. Severe and recurrent episodes of bronchiolitis obliterans organising pneumonia associated with indolent CD4⁺ CD8⁺ T-cell leukaemia. Eur Respir J. 31:1368-1372, 2008.

Hughes GJ, Cochrane A, Leen C, Morris S, Bell JE, Simmonds P. HIV-1-infected CD8⁺CD4⁺ T cells decay in vivo at a similar rate to infected CD4 T cells during HAART. AIDS. 22:57-65, 2008.

Ghia P, Prato G, Stella S, Scielzo C, Geuna M, Caligaris-Cappio F. Age-dependent accumulation of monoclonal CD4⁺CD8⁺ double positive T lymphocytes in the peripheral blood of the elderly. Br J Haematol. 139:780-90, 2007.

Parel Y, Aurrand-Lions M, Scheja A, Dayer JM, Roosnek E, Chizzolini C. Presence of CD4⁺CD8⁺ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis. Arthritis Rheum. 56:3459-67, 2007.

Rahemtullah A, Reichard KK, Preffer FI, Harris NL, Hasserjian RP. A double-positive CD4⁺CD8⁺ T-cell population is commonly found in nodular lymphocyte predominant Hodgkin lymphoma. Am J Clin Pathol. 126:805-814, 2006.

Alaibac M, Berti E, Chizzolini C, Fineschi S, Marzano AV, Pigozzi B, Riboldi E, Sozzani S, Kuhn A. Role of cellular immunity in the pathogenesis of autoimmune skin diseases. Clin Exp Rheumatol. 24(1 Suppl 40):S14-9, 2006.

Parel Y, Chizzolini C. CD4⁺ CD8⁺ double positive (DP) T cells in health and disease. Autoimmun Rev. 3:215-220, 2004.

Bricard G, Cesson V, Devevre E, Bouzourene H, Barbey C, Rufer N, Im JS, Alves PM, Martinet O, Halkic N, Cerottini JC, Romero P, Porcelli SA, Macdonald HR, Speiser DE. Enrichment of human CD4⁺ V(alpha)24/Vbeta11 invariant NKT cells in intrahepatic malignant tumors. J Immunol. 182:5140-5151, 2009.

Liu TY, Uemura Y, Suzuki M, Narita Y, Hirata S, Ohyama H, Ishihara O, Matsushita S. Distinct subsets of human invariant NKT cells differentially regulate T helper responses via dendritic cells. Eur J Immunol. 38:1012-23, 2008.

Montoya CJ, Pollard D, Martinson J, Kumari K, Wasserfall C, Mulder CB, Rugeles MT, Atkinson MA, Landay AL, Wilson SB. Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11. Immunology. 122:1-14, 2007.